BLIS K12
Also known as: Streptococcus Salivarius K12, Throat Probiotic
BLIS Technologies' oral probiotic strain, colonizes the throat and mouth, where it produces bacteriocins that compete with other oral bacteria.
- Clinical dose
- 1 billion CFU/day lozenge, the dose used in Di Pierro et al., 2014
- Typical label dose
- 1 billion CFU/day
- Category
- General Health
- Immunity
- Oral Health
- Throat Support
- Antimicrobial
What it is & how it works
Produces salivaricin A2 and B bacteriocins targeting S. pyogenes and other oral pathogens; colonizes oral cavity competitively excluding harmful bacteria.
Dosage
The clinically studied dose is 1 billion CFU/day lozenge, the dose used in Di Pierro et al., 2014.On labels you'll typically see 1 billion CFU/day.
What the research shows
Throat and oral-health formulas use BLIS K12 as a specialized oral-cavity colonizer with published pediatric trial data behind it.
Studies & citations
Formulas it appears in
- Immune Formula
- Gut Health
Immune Formula
Categories
BLIS K12 FAQ
What is BLIS K12?
BLIS Technologies' oral probiotic strain, colonizes the throat and mouth, where it produces bacteriocins that compete with other oral bacteria.
How much BLIS K12 should I take per day?
The clinically studied dose is 1 billion CFU/day lozenge, the dose used in Di Pierro et al., 2014.
What does BLIS K12 do?
Throat and oral-health formulas use BLIS K12 as a specialized oral-cavity colonizer with published pediatric trial data behind it.
What is BLIS K12 found in?
Immune Formula
Related General Health ingredients
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Educational information only, not medical advice, doses reflect published research. Check with a healthcare professional before starting any supplement.